Clinical trial
A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or…
NCT00036452 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00036452 |
|---|---|
| Title | A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation |
| Official title | A Randomized, Phase II, Open Label Study to Compare Twice Daily and Once Daily Potent Antiretroviral Therapy and to Compare Self-Administered Therapy and Therapy Administered Under Direct Observation |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | lopinavir/ritonavir, emtricitabine, stavudine, tenofovir DF |
| Enrollment | 402 |
| Completion | Jan 1, 2006 |
| First posted | May 13, 2002 |
| Last update posted | Nov 1, 2021 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: